Skip to content

Septerna, Inc. SEPN Shares (Diluted)

Shares (Diluted) at other companies

Amgen logo
AmgenAMGN
544M+0.6%
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
63.1M+6.2%
Nurix Therapeutics, Inc. logo
Nurix Therapeutics, Inc.NRIX
110.1M+31.7%
Rapport Therapeutics, Inc. logo
Rapport Therapeutics, Inc.RAPP
47.2M+33.9%
Precigen logo
PrecigenPGEN
354.3M+20.6%
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
126.9M0.0%

Other financials

Income statement

See full
Revenue$26.5M+12,011%
Operating income-$13.3M+48.7%
Net income-$8.6M+59.8%
EPS (diluted)-$0.19+61.2%

Balance sheet

See full
Cash & equivalents$71.6M-65.9%
Total debt$23.1M-7.7%
Total equity$378.5M+195%
Total assets$569.7M+31.3%

Cash flow

See full
Operating cash flow-$25.6M-9.8%
CapEx$832.0K+118%
Free cash flow-$26.5M-11.5%

Valuation

See full
Market cap$1.65B+319%
Enterprise value$1.6B+1,325%
P/S22.8×-379×

Profitability

See full
Operating margin-77.1%-38.4pp
Net margin-49.9%-24.9pp
FCF margin467.9%+243pp

Returns & leverage

See full
Return on equity-12.2%
Debt / equity0.1×
Current ratio4.7×-27.5×

Where this comes from

Reported directly by Septerna, Inc. in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.

The official record: Septerna, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Septerna, Inc.'s shares (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Septerna, Inc.'s shares (diluted)?
Septerna, Inc. (SEPN) reported shares (diluted) of 44.8M in Q1 2026.
How has Septerna, Inc.'s shares (diluted) changed year-over-year?
Septerna, Inc.'s shares (diluted) increased by 1.9% year-over-year, from 43.9M to 44.8M.
What does shares (diluted) mean?
The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.